PDB Short entry for 1M2Z HEADER HORMONE/HORMONE ACTIVATOR 26-JUN-02 1M2Z TITLE CRYSTAL STRUCTURE OF A DIMER COMPLEX OF THE HUMAN GLUCOCORTICOID TITLE 2 RECEPTOR LIGAND-BINDING DOMAIN BOUND TO DEXAMETHASONE AND A TIF2 TITLE 3 COACTIVATOR MOTIF CAVEAT 1M2Z BOG A 501 HAS WRONG CHIRALITY AT ATOM C2 BOG A 501 HAS WRONG CAVEAT 2 1M2Z CHIRALITY AT ATOM C3 BOG A 501 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 1M2Z C4 BOG A 501 HAS WRONG CHIRALITY AT ATOM C5 BOG A 778 HAS CAVEAT 4 1M2Z WRONG CHIRALITY AT ATOM C1 BOG A 778 HAS WRONG CHIRALITY AT CAVEAT 5 1M2Z ATOM C2 BOG A 778 HAS WRONG CHIRALITY AT ATOM C3 BOG A 778 CAVEAT 6 1M2Z HAS WRONG CHIRALITY AT ATOM C4 BOG A 778 HAS WRONG CAVEAT 7 1M2Z CHIRALITY AT ATOM C5 BOG A 779 HAS WRONG CHIRALITY AT ATOM CAVEAT 8 1M2Z C1 BOG A 779 HAS WRONG CHIRALITY AT ATOM C2 BOG A 779 HAS CAVEAT 9 1M2Z WRONG CHIRALITY AT ATOM C3 BOG A 779 HAS WRONG CHIRALITY AT CAVEAT 10 1M2Z ATOM C4 BOG A 779 HAS WRONG CHIRALITY AT ATOM C5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOCORTICOID RECEPTOR; COMPND 3 CHAIN: A, D; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 521-777; COMPND 5 SYNONYM: GR; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 10 CHAIN: B, E; COMPND 11 FRAGMENT: TIF2 COACTIVATOR MOTIF, RESIDUES 734-754; COMPND 12 SYNONYM: TRANSCRIPTIONAL INTERMEDIARY FACTOR 2, TIF2; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PET SYSTEM; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET24; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SOURCE OF SOURCE 13 THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS (HUMAN). KEYWDS GLUCOCORTICOID RECEPTOR, DEXAMETHASONE, TIF2, DIMER INTERFACE, KEYWDS 2 HORMONE BINDING POCKET, CHARGE CLAMP, COACTIVATOR, HORMONE-HORMONE KEYWDS 3 ACTIVATOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.B.BLEDSOE,V.G.MONTANA,T.B.STANLEY,C.J.DELVES,C.J.APOLITO,D.D.MCKEE, AUTHOR 2 T.G.CONSLER,D.J.PARKS,E.L.STEWART,T.M.WILLSON,M.H.LAMBERT,J.T.MOORE, AUTHOR 3 K.H.PEARCE,H.E.XU REVDAT 7 03-APR-24 1M2Z 1 REMARK REVDAT 6 14-FEB-24 1M2Z 1 REMARK REVDAT 5 27-OCT-21 1M2Z 1 SEQADV HETSYN REVDAT 4 29-JUL-20 1M2Z 1 CAVEAT COMPND REMARK HETNAM REVDAT 4 2 1 SITE REVDAT 3 11-OCT-17 1M2Z 1 REMARK REVDAT 2 24-FEB-09 1M2Z 1 VERSN REVDAT 1 15-JUL-03 1M2Z 0 JRNL AUTH R.B.BLEDSOE,V.G.MONTANA,T.B.STANLEY,C.J.DELVES,C.J.APOLITO, JRNL AUTH 2 D.D.MCKEE,T.G.CONSLER,D.J.PARKS,E.L.STEWART,T.M.WILLSON, JRNL AUTH 3 M.H.LAMBERT,J.T.MOORE,K.H.PEARCE,H.E.XU JRNL TITL CRYSTAL STRUCTURE OF THE GLUCOCORTICOID RECEPTOR LIGAND JRNL TITL 2 BINDING DOMAIN REVEALS A NOVEL MODE OF RECEPTOR DIMERIZATION JRNL TITL 3 AND COACTIVATOR RECOGNITION JRNL REF CELL(CAMBRIDGE,MASS.) V. 110 93 2002 JRNL REFN ISSN 0092-8674 JRNL PMID 12151000 JRNL DOI 10.1016/S0092-8674(02)00817-6 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 81.8 REMARK 3 NUMBER OF REFLECTIONS : 21317 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.267 REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1713 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 27314 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 49.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1958 REMARK 3 BIN R VALUE (WORKING SET) : 0.2920 REMARK 3 BIN FREE R VALUE : 0.3220 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 168 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.025 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4476 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 101 REMARK 3 SOLVENT ATOMS : 205 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 62.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 67.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.45000 REMARK 3 B22 (A**2) : -8.45000 REMARK 3 B33 (A**2) : 16.90000 REMARK 3 B12 (A**2) : 4.52000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.42 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.40 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.800 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.230 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.930 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 5.410 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.620 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 71.21 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : LOCALPARM.XPL REMARK 3 PARAMETER FILE 4 : BSXPI3_BOND.XPL REMARK 3 PARAMETER FILE 5 : X.XPRM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1M2Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JUL-02. REMARK 100 THE DEPOSITION ID IS D_1000016532. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MAR CCD 165 MM REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MACSCIENCE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27095 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 10.00 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : 0.08200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 35.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 10.00 REMARK 200 R MERGE FOR SHELL (I) : 0.71800 REMARK 200 R SYM FOR SHELL (I) : 0.71800 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AMORE REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: GR MODEL BUILT ON THE PR STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SALTS, PH 8.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 28.65867 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 57.31733 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 42.98800 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 71.64667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 14.32933 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THIS STRUCTURE CONTAINS: REMARK 400 1. A NOVEL LBD-LBD DIMER REMARK 400 2. A NOVEL CHARGE CLAMP FOR COACTIVATOR RECOGNITION REMARK 400 3. A UNIQUE STEROID BINDING POCKET REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 521 REMARK 465 PRO A 522 REMARK 465 VAL D 521 REMARK 465 PRO D 522 REMARK 465 ALA D 523 REMARK 465 THR D 524 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU D 525 CB CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLN A 527 N - CA - C ANGL. DEV. = 21.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 526 155.30 -43.50 REMARK 500 GLN A 527 34.84 19.73 REMARK 500 PRO A 530 152.24 -32.17 REMARK 500 PRO A 553 152.42 -49.58 REMARK 500 SER A 555 149.02 -178.15 REMARK 500 ARG A 585 32.59 -85.81 REMARK 500 SER A 599 19.96 -149.05 REMARK 500 SER A 616 32.75 -162.97 REMARK 500 CYS A 622 74.32 -101.31 REMARK 500 PRO A 637 -90.92 -39.80 REMARK 500 ASP A 742 79.37 -174.28 REMARK 500 SER A 746 72.55 45.52 REMARK 500 ILE A 761 -39.77 -37.75 REMARK 500 TYR A 764 39.14 -86.71 REMARK 500 SER A 765 -47.09 -155.36 REMARK 500 LYS B 739 96.03 -52.01 REMARK 500 LYS B 740 -72.63 141.44 REMARK 500 GLU B 741 94.76 -35.93 REMARK 500 ASN B 742 67.34 79.66 REMARK 500 LYS B 751 88.17 160.79 REMARK 500 ASP B 753 -93.75 -40.45 REMARK 500 LEU D 528 52.91 37.41 REMARK 500 SER D 555 133.05 178.94 REMARK 500 SER D 599 19.51 -140.88 REMARK 500 SER D 616 33.55 -141.30 REMARK 500 CYS D 622 73.41 -100.05 REMARK 500 PRO D 625 -19.28 -40.09 REMARK 500 PRO D 637 -38.51 -29.27 REMARK 500 LYS D 677 93.99 -67.64 REMARK 500 ASP D 678 -44.89 155.92 REMARK 500 GLU D 705 -95.15 -71.61 REMARK 500 ASN D 707 -105.50 151.46 REMARK 500 SER D 708 -26.65 160.62 REMARK 500 ILE D 761 -65.81 -18.33 REMARK 500 PRO D 762 -71.45 -66.20 REMARK 500 TYR D 764 -75.85 -71.94 REMARK 500 ASN D 766 -70.94 -45.86 REMARK 500 SER E 736 68.94 -164.91 REMARK 500 PRO E 737 161.39 -47.39 REMARK 500 LYS E 738 35.34 76.20 REMARK 500 LYS E 751 -160.40 -53.28 REMARK 500 ASP E 752 142.22 99.02 REMARK 500 ASP E 753 -78.11 165.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 THE ATOMS OF THE DETERGENT, BOG, B-OCTYLGLUCOSIDE, REMARK 600 ARE ONLY PARTIALLY SEEN IN THE STRUCTURE. REMARK 600 THE OCTANE CHAIN IS MISSING IN BOG 601. REMARK 600 6 ATOMS OF THE OCTANE CHAIN ARE MISSING IN BOG 701. REMARK 600 THE O1 IS MISSING IN BOG 501. REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 BOG A 501 REMARK 610 BOG A 778 REMARK 610 BOG A 779 DBREF 1M2Z A 521 777 UNP P04150 GCR_HUMAN 521 777 DBREF 1M2Z B 734 754 UNP Q15596 NCOA2_HUMAN 734 754 DBREF 1M2Z D 521 777 UNP P04150 GCR_HUMAN 521 777 DBREF 1M2Z E 734 754 UNP Q15596 NCOA2_HUMAN 734 754 SEQADV 1M2Z SER A 602 UNP P04150 PHE 602 ENGINEERED MUTATION SEQADV 1M2Z SER D 602 UNP P04150 PHE 602 ENGINEERED MUTATION SEQRES 1 A 257 VAL PRO ALA THR LEU PRO GLN LEU THR PRO THR LEU VAL SEQRES 2 A 257 SER LEU LEU GLU VAL ILE GLU PRO GLU VAL LEU TYR ALA SEQRES 3 A 257 GLY TYR ASP SER SER VAL PRO ASP SER THR TRP ARG ILE SEQRES 4 A 257 MET THR THR LEU ASN MET LEU GLY GLY ARG GLN VAL ILE SEQRES 5 A 257 ALA ALA VAL LYS TRP ALA LYS ALA ILE PRO GLY PHE ARG SEQRES 6 A 257 ASN LEU HIS LEU ASP ASP GLN MET THR LEU LEU GLN TYR SEQRES 7 A 257 SER TRP MET SER LEU MET ALA PHE ALA LEU GLY TRP ARG SEQRES 8 A 257 SER TYR ARG GLN SER SER ALA ASN LEU LEU CYS PHE ALA SEQRES 9 A 257 PRO ASP LEU ILE ILE ASN GLU GLN ARG MET THR LEU PRO SEQRES 10 A 257 CYS MET TYR ASP GLN CYS LYS HIS MET LEU TYR VAL SER SEQRES 11 A 257 SER GLU LEU HIS ARG LEU GLN VAL SER TYR GLU GLU TYR SEQRES 12 A 257 LEU CYS MET LYS THR LEU LEU LEU LEU SER SER VAL PRO SEQRES 13 A 257 LYS ASP GLY LEU LYS SER GLN GLU LEU PHE ASP GLU ILE SEQRES 14 A 257 ARG MET THR TYR ILE LYS GLU LEU GLY LYS ALA ILE VAL SEQRES 15 A 257 LYS ARG GLU GLY ASN SER SER GLN ASN TRP GLN ARG PHE SEQRES 16 A 257 TYR GLN LEU THR LYS LEU LEU ASP SER MET HIS GLU VAL SEQRES 17 A 257 VAL GLU ASN LEU LEU ASN TYR CYS PHE GLN THR PHE LEU SEQRES 18 A 257 ASP LYS THR MET SER ILE GLU PHE PRO GLU MET LEU ALA SEQRES 19 A 257 GLU ILE ILE THR ASN GLN ILE PRO LYS TYR SER ASN GLY SEQRES 20 A 257 ASN ILE LYS LYS LEU LEU PHE HIS GLN LYS SEQRES 1 B 21 PRO VAL SER PRO LYS LYS LYS GLU ASN ALA LEU LEU ARG SEQRES 2 B 21 TYR LEU LEU ASP LYS ASP ASP THR SEQRES 1 D 257 VAL PRO ALA THR LEU PRO GLN LEU THR PRO THR LEU VAL SEQRES 2 D 257 SER LEU LEU GLU VAL ILE GLU PRO GLU VAL LEU TYR ALA SEQRES 3 D 257 GLY TYR ASP SER SER VAL PRO ASP SER THR TRP ARG ILE SEQRES 4 D 257 MET THR THR LEU ASN MET LEU GLY GLY ARG GLN VAL ILE SEQRES 5 D 257 ALA ALA VAL LYS TRP ALA LYS ALA ILE PRO GLY PHE ARG SEQRES 6 D 257 ASN LEU HIS LEU ASP ASP GLN MET THR LEU LEU GLN TYR SEQRES 7 D 257 SER TRP MET SER LEU MET ALA PHE ALA LEU GLY TRP ARG SEQRES 8 D 257 SER TYR ARG GLN SER SER ALA ASN LEU LEU CYS PHE ALA SEQRES 9 D 257 PRO ASP LEU ILE ILE ASN GLU GLN ARG MET THR LEU PRO SEQRES 10 D 257 CYS MET TYR ASP GLN CYS LYS HIS MET LEU TYR VAL SER SEQRES 11 D 257 SER GLU LEU HIS ARG LEU GLN VAL SER TYR GLU GLU TYR SEQRES 12 D 257 LEU CYS MET LYS THR LEU LEU LEU LEU SER SER VAL PRO SEQRES 13 D 257 LYS ASP GLY LEU LYS SER GLN GLU LEU PHE ASP GLU ILE SEQRES 14 D 257 ARG MET THR TYR ILE LYS GLU LEU GLY LYS ALA ILE VAL SEQRES 15 D 257 LYS ARG GLU GLY ASN SER SER GLN ASN TRP GLN ARG PHE SEQRES 16 D 257 TYR GLN LEU THR LYS LEU LEU ASP SER MET HIS GLU VAL SEQRES 17 D 257 VAL GLU ASN LEU LEU ASN TYR CYS PHE GLN THR PHE LEU SEQRES 18 D 257 ASP LYS THR MET SER ILE GLU PHE PRO GLU MET LEU ALA SEQRES 19 D 257 GLU ILE ILE THR ASN GLN ILE PRO LYS TYR SER ASN GLY SEQRES 20 D 257 ASN ILE LYS LYS LEU LEU PHE HIS GLN LYS SEQRES 1 E 21 PRO VAL SER PRO LYS LYS LYS GLU ASN ALA LEU LEU ARG SEQRES 2 E 21 TYR LEU LEU ASP LYS ASP ASP THR HET BOG A 501 19 HET BOG A 778 12 HET BOG A 779 14 HET DEX A 301 29 HET DEX D 401 28 HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETNAM DEX DEXAMETHASONE HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE HETSYN DEX 9A-FLUORO-16BETA-METHYLPREDNISOLONE FORMUL 5 BOG 3(C14 H28 O6) FORMUL 8 DEX 2(C22 H29 F O5) FORMUL 10 HOH *205(H2 O) HELIX 1 1 THR A 531 GLU A 540 1 10 HELIX 2 2 SER A 555 LYS A 579 1 25 HELIX 3 3 GLY A 583 LEU A 587 5 5 HELIX 4 4 HIS A 588 SER A 617 1 30 HELIX 5 5 ASN A 630 THR A 635 1 6 HELIX 6 6 CYS A 638 LEU A 656 1 19 HELIX 7 7 SER A 659 LEU A 672 1 14 HELIX 8 8 SER A 682 GLU A 705 1 24 HELIX 9 9 GLN A 710 LEU A 741 1 32 HELIX 10 10 ASP A 742 SER A 746 5 5 HELIX 11 11 PRO A 750 ILE A 761 1 12 HELIX 12 12 PRO A 762 GLY A 767 1 6 HELIX 13 13 ASN B 742 LEU B 749 1 8 HELIX 14 14 THR D 531 ILE D 539 1 9 HELIX 15 15 SER D 555 ILE D 581 1 27 HELIX 16 16 HIS D 588 SER D 617 1 30 HELIX 17 17 ASN D 630 THR D 635 1 6 HELIX 18 18 CYS D 638 LEU D 656 1 19 HELIX 19 19 SER D 659 LEU D 672 1 14 HELIX 20 20 SER D 682 LYS D 703 1 22 HELIX 21 21 SER D 708 LEU D 741 1 34 HELIX 22 22 PRO D 750 GLY D 767 1 18 HELIX 23 23 ASN E 742 LYS E 751 1 10 SHEET 1 A 2 LEU A 621 ALA A 624 0 SHEET 2 A 2 LEU A 627 ILE A 629 -1 O ILE A 629 N LEU A 621 SHEET 1 B 2 SER A 674 PRO A 676 0 SHEET 2 B 2 ILE A 769 LYS A 771 -1 O LYS A 770 N VAL A 675 SHEET 1 C 2 LEU D 621 ALA D 624 0 SHEET 2 C 2 LEU D 627 ILE D 629 -1 O LEU D 627 N ALA D 624 SHEET 1 D 2 SER D 674 PRO D 676 0 SHEET 2 D 2 ILE D 769 LYS D 771 -1 O LYS D 770 N VAL D 675 CISPEP 1 LEU A 525 PRO A 526 0 0.18 CRYST1 125.843 125.843 85.976 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007946 0.004588 0.000000 0.00000 SCALE2 0.000000 0.009176 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011631 0.00000